Pelvic exam in Gynecology and Obstetrics: French Guidelines for Clinical Practice
- PMID: 37871350
- DOI: 10.1016/j.ejogrb.2023.10.007
Pelvic exam in Gynecology and Obstetrics: French Guidelines for Clinical Practice
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: AF: SELAS Pointgyn, Laboratoire Innotech International, Respiratory and Women’s Health Products, Center for observational and real-world evidence (CORE);CLR: Ferring;CRJ:Bayer, Bristol Myers Squibb, Merck Serono Healthcare, Mylan, Roche, Theramex;ES: Evalformsanté;HB: Organon, Bayer, Gédéon Richter, MSD vaccins, Exeltix, Besins;LMM: Ferring, Vichy, Ipsen, Evalformsanté, Besins, Gédéon Richter, Effik, Theramex;MB: Gédéon Richter;ML: Theramex, Gédéon Richter, Ferring, IBSA Pharma, Merck, Serono, Organon and Exeltis;SM: HAS;TB:Nordic Pharma;VB: Merck, IBSA Pharma and Besins-HealthCare, Theramex, Gedeon Richter, Ferring, IBSA Pharma, Merck Serono, Organon and Exeltis;VG: PFIZER and HAC pharma;XD: Sanofi, Astellas, Coloplast, Hologic, IBSA Pharma, Laborie, Mylan, Pierre-Fabre, Elsevier-Masson, Regimedia and HealthEvents;YA: Conférences Hermes;YC: HAS. Other authors declared no C.O.I.
MeSH terms
LinkOut - more resources
Full Text Sources